Studies on diketopiperazine and dipeptide analogs as opioid receptor ligands

European Journal of Medicinal Chemistry - Tập 254 - Trang 115309 - 2023
Siavash Shahbazi Nia1, Mohammad Anwar Hossain1, Guangchen Ji2,3, Sravan K. Jonnalagadda4, Samuel Obeng5, Md Ashrafur Rahman1, Ali Ehsan Sifat1, Saeideh Nozohouri1, Collin Blackwell1, Dhavalkumar Patel6, Jon Thompson7, Scott Runyon8, Takato Hiranita9, Christopher R. McCurdy10, Lance McMahon1, Thomas J. Abbruscato1, Paul C. Trippier4,11, Volker Neugebauer2,3,12, Nadezhda A. German1,3
1Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, 79106, USA
2Department of Pharmacology and Neuroscience, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA
3Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA
4Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA
5Department of Pharmaceutical, Social and Administrative Sciences, McWhorter School of Pharmacy, Samford University, Birmingham, AL, 35229, USA
6Office of Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, 79106, USA
7Veterinary School of Medicine, Texas Tech University, Amarillo, TX, 79106, USA
8Reserach Triangle Institute, Research Triangle Park, Durham, NC, 27709, USA
9Department of Pharmacology, University of Texas Health San Antonio, San Antonio, TX 78229, USA
10Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL, 32610, USA
11UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, NE, 68106, USA
12Garrison Institute on Aging, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA

Tài liệu tham khảo

2018, 1001

Gaskin, 2012, The economic costs of pain in the United States, J. Pain, 13, 715, 10.1016/j.jpain.2012.03.009

Colloca, 2017, Neuropathic pain, Nat. Rev. Dis. Prim., 3

2018, 1001

Galluzzi, 2005, Management of neuropathic pain, J. Am. Osteopath. Assoc., 105, S12

DiBonaventura, 2017, The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health survey, J. Pain Res., 10, 2525, 10.2147/JPR.S127014

Mao, 2020, Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in wuhan, China, JAMA Neurol., 77, 683, 10.1001/jamaneurol.2020.1127

Aksan, 2020, A COVID-19 patient with intense burning pain, J. Neurovirol., 26, 800, 10.1007/s13365-020-00887-4

Frontera, 2020, A prospective study of neurologic disorders in hospitalized COVID-19 patients in New York city, Neurology, 96, e575, 10.1212/WNL.0000000000010979

Wei, 2019, Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: a cross-sectional study, PLoS Med., 16, 10.1371/journal.pmed.1002941

Chang, 2018, Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study, BMC Med., 16, 69, 10.1186/s12916-018-1058-y

Rasmussen, 2019, NIDA's medication development priorities in response to the opioid crisis: ten most wanted, Neuropsychopharmacology, 44, 657, 10.1038/s41386-018-0292-5

Crime

Cahill, 2014, Does the kappa opioid receptor system contribute to pain aversion?, Front. Pharmacol., 5, 253, 10.3389/fphar.2014.00253

Xie, 2017, Kappa opioid receptor antagonists: a possible new class of therapeutics for migraine prevention, Cephalalgia, 37, 780, 10.1177/0333102417702120

Nation, 2018, Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain, Pain, 159, 919, 10.1097/j.pain.0000000000001167

Navratilova, 2019, Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain, Pain, 160, 824, 10.1097/j.pain.0000000000001458

Land, 2008, The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system, J. Neurosci., 28, 407, 10.1523/JNEUROSCI.4458-07.2008

Bruchas, 2010, The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors, Brain Res., 1314, 44, 10.1016/j.brainres.2009.08.062

Smith, 2012, Stress-induced activation of the dynorphin/kappa-opioid receptor system in the amygdala potentiates nicotine conditioned place preference, J. Neurosci., 32, 1488, 10.1523/JNEUROSCI.2980-11.2012

Lalanne, 2014, The kappa opioid receptor: from addiction to depression, and back, Front. Psychiatr., 5, 170, 10.3389/fpsyt.2014.00170

Crowley, 2016, Dynorphin controls the gain of an amygdalar anxiety circuit, Cell Rep., 14, 2774, 10.1016/j.celrep.2016.02.069

Tejeda, 2017, Pathway- and cell-specific kappa-opioid receptor modulation of excitation-inhibition balance differentially gates D1 and D2 accumbens neuron activity, Neuron, 93, 147, 10.1016/j.neuron.2016.12.005

Mague, 2003, Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats, J. Pharmacol. Exp. Therapeut., 305, 323, 10.1124/jpet.102.046433

McLaughlin, 2003, Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses, J. Neurosci., 23, 5674, 10.1523/JNEUROSCI.23-13-05674.2003

Schank, 2012, The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety, Addiction Biol., 17, 634, 10.1111/j.1369-1600.2012.00455.x

Robledo, 2008, Advances in the field of cannabinoid--opioid cross-talk, Addiction Biol., 13, 213, 10.1111/j.1369-1600.2008.00107.x

Davis, 2009, Opioid receptors and opioid pharmacodynamics

Massaly, 2019, Pain-induced negative affect is mediated via recruitment of the nucleus accumbens kappa opioid system, Neuron, 102, 564, 10.1016/j.neuron.2019.02.029

Yakhnitsa, 2022, Kappa opioid receptor blockade in the amygdala mitigates pain like-behaviors by inhibiting corticotropin releasing factor neurons in a rat model of functional pain, Front. Pharmacol., 13, 10.3389/fphar.2022.903978

Ito, 2023, Chronic pain recruits hypothalamic dynorphin/kappa opioid receptor signalling to promote wakefulness and vigilance, Brain, 146, 1186, 10.1093/brain/awac153

Gardiner, 2005, The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis, Microbiology, 151, 1021, 10.1099/mic.0.27847-0

Scharf, 2016, Gliotoxin--Bane or boon?, Environ. Microbiol., 18, 1096, 10.1111/1462-2920.13080

Scharf, 2010, Transannular disulfide formation in gliotoxin biosynthesis and its role in self-resistance of the human pathogen Aspergillus fumigatus, J. Am. Chem. Soc., 132, 10136, 10.1021/ja103262m

Card, 2005, A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design, Nat. Biotechnol., 23, 201, 10.1038/nbt1059

Nadin, 2012, Lead-oriented synthesis: a new opportunity for synthetic chemistry, Angew. Chem. Int. Ed., 51, 1114, 10.1002/anie.201105840

Vaz, 2003, Determination of the absolute stereochemistry of etzionin, Tetrahedron: Asymmetry, 14, 1935, 10.1016/S0957-4166(03)00403-8

Armstrong, 2014, Catalytic enantioselective synthesis of atropisomeric biaryls: a cation-directed nucleophilic aromatic substitution reaction, Angew Chem. Int. Ed. Engl., 53, 12822, 10.1002/anie.201408205

Emery, 2016, C–C bond-forming reactions of ground-state aryl halides under reductive activation, Tetrahedron, 72, 7875, 10.1016/j.tet.2016.05.083

Tullis, 2001, The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold, Bioorg. Med. Chem. Lett, 11, 1975, 10.1016/S0960-894X(01)00371-7

Danner, 2005, Total synthesis of cryptophycin 3, Eur. J. Org Chem., 317, 10.1002/ejoc.200400558

McMahon, 2011, A scaleable formal total synthesis of dehydrogliotoxin, Tetrahedron Lett., 52, 2262, 10.1016/j.tetlet.2011.01.138

Besnard, 2012, Automated design of ligands to polypharmacological profiles, Nature, 492, 215, 10.1038/nature11691

Roth

O'Connor, 2015, NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor, Proc. Natl. Acad. Sci. U. S. A., 112, 11852, 10.1073/pnas.1510117112

Wager, 2010, Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties, ACS Chem. Neurosci., 1, 435, 10.1021/cn100008c

Johnson, 2018, Lipophilic efficiency as an important metric in drug design, J. Med. Chem., 61, 6401, 10.1021/acs.jmedchem.8b00077

Veber, 2002, Molecular properties that influence the oral bioavailability of drug candidates, J. Med. Chem., 45, 2615, 10.1021/jm020017n

Rankovic, 2015, CNS drug design: balancing physicochemical properties for optimal brain exposure, J. Med. Chem., 58, 2584, 10.1021/jm501535r

Wager, 2016, Central nervous system multiparameter optimization desirability: application in drug discovery, ACS Chem. Neurosci., 7, 767, 10.1021/acschemneuro.6b00029

Bahar, 2012, Species difference of esterase expression and hydrolase activity in plasma, J. Pharmaceut. Sci., 101, 3979, 10.1002/jps.23258

Li, 2005, Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma, Biochem. Pharmacol., 70, 1673, 10.1016/j.bcp.2005.09.002

Al Shoyaib, 2019, Intraperitoneal route of drug administration: should it Be used in experimental animal studies?, Pharm. Res. (N. Y.), 37, 12, 10.1007/s11095-019-2745-x

Qvit, 2017, Peptidomimetic therapeutics: scientific approaches and opportunities, Drug Discov. Today, 22, 454, 10.1016/j.drudis.2016.11.003

Karatas, 2017, Discovery of a highly potent, cell-permeable macrocyclic peptidomimetic (MM-589) targeting the WD repeat domain 5 protein (WDR5)-Mixed lineage leukemia (MLL) protein-protein interaction, J. Med. Chem., 60, 4818, 10.1021/acs.jmedchem.6b01796

Zhou, 2018, High-affinity peptidomimetic inhibitors of the DCN1-UBC12 protein-protein interaction, J. Med. Chem., 61, 1934, 10.1021/acs.jmedchem.7b01455

Peckys, 1999, Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study, Neuroscience, 88, 1093, 10.1016/S0306-4522(98)00251-6

Hein, 2021, Kappa opioid receptor activation in the amygdala disinhibits CRF neurons to generate pain-like behaviors, Neuropharmacology, 185, 10.1016/j.neuropharm.2021.108456

Ji, 2020, Kappa opioid receptors in the central amygdala modulate spinal nociceptive processing through an action on amygdala CRF neurons, Mol. Brain, 13, 128, 10.1186/s13041-020-00669-3

Liu, 2016, Neuropathic pain alters reward and affect via kappa opioid receptor (KOR) upregulation, Faseb. J., 30

Kim, 1992, An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat, Pain, 50, 355, 10.1016/0304-3959(92)90041-9

Mazzitelli, 2022, Optogenetic manipulations of CeA-CRF neurons modulate pain- and anxiety-like behaviors in neuropathic pain and control rats, Neuropharmacology, 210, 10.1016/j.neuropharm.2022.109031

Presto, 2022, Sex differences in CGRP regulation and function in the amygdala in a rat model of neuropathic pain, Front. Mol. Neurosci., 15, 10.3389/fnmol.2022.928587

Presto, 2021, Fear extinction-based inter-individual and sex differences in pain-related vocalizations and anxiety-like behaviors but not nocifensive reflexes, Brain Sci., 11, 10.3390/brainsci11101339

Navratilova, 2020, Selective modulation of tonic aversive qualities of neuropathic pain by morphine in the central nucleus of the amygdala requires endogenous opioid signaling in the anterior cingulate cortex, Pain, 161, 609, 10.1097/j.pain.0000000000001748

Rarey, 1996, A fast flexible docking method using an incremental construction algorithm, J. Mol. Biol., 261, 470, 10.1006/jmbi.1996.0477

Lemmen, 1998, FLEXS: a method for fast flexible ligand superposition, J. Med. Chem., 41, 4502, 10.1021/jm981037l

Schneider, 2013, A consistent description of HYdrogen bond and DEhydration energies in protein-ligand complexes: methods behind the HYDE scoring function, J. Comput. Aided Mol. Des., 27, 15, 10.1007/s10822-012-9626-2

Ashraf-Uz-Zaman, 2021, Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer, Eur. J. Med. Chem., 209, 10.1016/j.ejmech.2020.112866

Wang, 2017, Synthesis and antineoplastic evaluation of mitochondrial complex II (succinate dehydrogenase) inhibitors derived from atpenin A5, ChemMedChem, 12, 1033, 10.1002/cmdc.201700196

Volkamer, 2012, DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment, Bioinformatics, 28, 2074, 10.1093/bioinformatics/bts310

Nozohouri, 2021, Estimating brain permeability using in vitro blood-brain barrier models, Methods Mol. Biol., 2367, 47, 10.1007/7651_2020_311

Knights, 2016, In vitro drug metabolism using liver microsomes, Curr. Protoc. Pharmacol., 74, 10.1002/cpph.9

Poulin, 2012, In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods, J. Pharmaceut. Sci., 101, 838, 10.1002/jps.22792

Riley, 2005, A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes, Drug Metab. Dispos., 33, 1304, 10.1124/dmd.105.004259

Rahman, 2021, Discovery of first-in-class peptidomimetic neurolysin activators possessing enhanced brain penetration and stability, J. Med. Chem., 64, 12705, 10.1021/acs.jmedchem.1c00759

Gritsch, 2016, Functional characterization of a mouse model for central post-stroke pain, Mol. Pain, 12, 10.1177/1744806916629049

Rahman, 2020, Blockade of the M1 muscarinic acetylcholine receptors impairs eyeblink serial feature-positive discrimination learning in mice, PLoS One, 15, 10.1371/journal.pone.0237451

Ji, 2017, 5-HT2C receptor knockdown in the amygdala inhibits neuropathic-pain-related plasticity and behaviors, J. Neurosci., 37, 1378, 10.1523/JNEUROSCI.2468-16.2016

Thompson, 2018, Small conductance calcium activated potassium (SK) channel dependent and independent effects of riluzole on neuropathic pain-related amygdala activity and behaviors in rats, Neuropharmacology, 138, 219, 10.1016/j.neuropharm.2018.06.015

Ji, 2019, Contribution of corticotropin-releasing factor receptor 1 (CRF1) to serotonin receptor 5-HT2CR function in amygdala neurons in a neuropathic pain model, Int. J. Mol. Sci., 20, 10.3390/ijms20184380

Thông tin
Thông tin xuất bản

European Journal of Medicinal Chemistry

Tập 254

115309

Thông tin tác giả